Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation

Pediatric Blood and Cancer

Volumn 61, Issue 2, 2014, Pages 376-379

  Di Nardo, Matteo ^a   Li Pira, Giuseppina ^a   Amodeo, Antonio ^a   Cecchetti, Corrado ^a   Giorda, Ezio ^a   Ceccarelli, Stefano ^a   Brescia, Letizia P ^a   Pirozzi, Nicola ^b   Rutella, Sergio ^a   Locatelli, Franco ^a   Bertaina, Alice ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NONE

Author keywords

Adenovirus; ECMO; Immune recovery; Immunotherapy; Stem cell transplantation; T lymphocyte

Indexed keywords

ANTIBIOTIC AGENT; CIDOFOVIR; FLUDARABINE; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILD; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; GENERAL CONDITION DETERIORATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN ADENOVIRUS INFECTION; INTENSIVE CARE UNIT; LEUKAPHERESIS; LUNG LAVAGE; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHOOL CHILD; T CELL DEPLETION; T LYMPHOCYTE; VIRUS LOAD;

EID: 84890863790     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24753     Document Type: Article

References (17)

1. Savoia A, Dufour C, Locatelli F, et al. Congenital amegakaryocytic thrombocytopenia: Clinical and biological consequences of five novel mutations. Haematologica 2007; 92:1186-1193.
2. Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: Clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 2011; 37:673-681.
3. Moss P, Rickinson A. Cellular immunotherapy for viral infection after HSC transplantation. Nat Rev Immunol 2005; 5:9-20.
4. Leen AM, Heslop HE. Cytotoxic T lymphocytes as immune-therapy in haematological practice. Br J Haematol 2008; 143:169-179.
5. Gow KW, Wulkan ML, Heiss KF, et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: The Extracorporeal Life Support Organization experience. J Pediatr Surg 2006; 41:662-667.
6. Bernardo ME, Piras E, Vacca A, et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 2012; 120:473-476.
7. Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010; 116:5476-5485.
8. + cells: Analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108:105-115.
9. Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: Summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14:555-563.
10. Li Pira G, Kapp M, Manca F, et al. Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host. Curr Opin Immunol 2009; 21:549-556.
11. Sili U, Leen AM, Vera JF, et al. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant. Cytotherapy 2012; 14:7-11.
12. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134:64-76.
13. Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116:4360-4367.
14. Feuchtinger T, Richard C, Joachim S, et al. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J Immunother 2008; 31:199-206.
15. + T cells according to IFN-γ secretion for adjuvant immunotherapy. Exp Hematol 2004; 32:282-289.
16. + adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica 2010; 95:1943-1951.
17. low/neg accessory cells with dendritic-cell features. Blood 2006; 108:218-227.